Patent details

EP2727918 Title: Compounds and Compositions as Protein Kinase Inhibitors

Basic Information

Publication number:
EP2727918
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP141529453
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Compounds and Compositions as Protein Kinase Inhibitors
French Title of Invention:
Composés et compositions en tant qu'inhibiteurs de protéine kinase
German Title of Invention:
Verbindungen und Zusammensetzungen als Proteinkinase-Inhibitoren
SPC Number:
LUC00102

Dates

Filing date:
27/08/2010
Grant date:
12/10/2016
EP Publication Date:
12/10/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/05/2014
EP B1 Publication Date:
12/10/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
27/08/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/05/2021
 
 

Name:
Array BioPharma Inc.
Address:
3200 Walnut Street, Boulder, CO 80301, United States (US)

History of Owners

From:
27/08/2010
To:
31/05/2021

Name:
Array BioPharma Inc.
Address:
3200 Walnut Street, Boulder, CO 80301, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
04/01/2017
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Poon Daniel
Address:
United States (US)

2

Name:
Wan Yongqin
Address:
United States (US)

3

Name:
Liu Zuosheng
Address:
United States (US)

4

Name:
Jin Xianming
Address:
United States (US)

5

Name:
Wang Xing
Address:
United States (US)

6

Name:
Tellew John
Address:
United States (US)

7

Name:
Xie Yongping
Address:
United States (US)

8

Name:
Huang Shenlin
Address:
United States (US)

Licencee

Name:
PIERRE FABRE MEDICAMENT
From:
25/06/2018
Address:
PLACE ABEL- GANCE 45, 92100, BOULOGNE, France (FR)
To:

Priority

1

Priority Number:
238073 P
Priority Date:
28/08/2009
Priority Country:
United States (US)

2

Priority Number:
313039 P
Priority Date:
11/03/2010
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 401/14;

Publication

Bulletin

1

Bulletin Heading:
MED
Bulletin edition number:
2018/08
Publication date:
06/07/2018
Description:
Section K : Modifications and recordals into the register

2

Bulletin Heading:
CO
Bulletin edition number:
2021/07
Publication date:
03/06/2021
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Licence

Change Kind/ Decision Type:
New licence registration
Deed Number:
RC20180000222A
Date Registered:
25/06/2018
Licence Effective Date:
25/06/2018
Licence Expiration Date:
Scope of Licence:
Exclusive
Deed Filer:
NOVAGRAAF TECHNOLOGIES
Journal Edition Number:
Text:
Licence restricted to component "ENCORAFENIB"
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Licencee(s)

Name:
PIERRE FABRE MEDICAMENT
Address:
PLACE ABEL- GANCE 45, 92100, BOULOGNE, France (FR)

Removed Pledgee

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20210000208B
Date Registered:
31/05/2021
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
fusion-absorption
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Array BioPharma Inc.
Address:
3200 Walnut Street, Boulder, CO 80301, United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
31/08/2026
Annual Fee Number:
17
Annual Fee Amount:
246 Euro
Expected Payer:
Last Annual Fee Payment Date:
10/07/2025
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
31/05/2021 Outgoing Correspondence 2
27/06/2018 Outgoing Correspondence 1
04/01/2017 Incoming Correspondence (Post) 1
31/05/2021 Request For Change 9
25/06/2018 Request For Change 8